"moderate" MCQ (SBA): Nephrology
Instant feedback + full explanation. One question, done properly.
Moderate"KDIGO recommends SGLT2 inhibitors for CKD and albuminuria down to eGFR ~20; they reduce renal and CV events. They do not replace RAAS blockade; DKA can occur rarely in T2D; albuminuria typically decreases."Nephrology"moderate"
Educational content. Not a substitute for clinical judgement or local policy.